D. G. Kieback

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Cornelis JH van de Velde, Daniel Rea, Caroline Seynaeve et al. · The Lancet · 2011 · 377 citations

Medicine, Oncology, Pharmacology +15

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

John M.S. Bartlett, Cassandra Brookes, Tammy Robson et al. · Journal of Clinical Oncology · 2011 · 198 citations · Full text

Medicine, Oncology, Pathology +17

Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

Vicky S. Sabine, Cheryl Crozier, Cassandra Brookes et al. · Journal of Clinical Oncology · 2014 · 136 citations

Medicine, Genetics, Oncology +17

Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study

C. Oberhoff, D. G. Kieback, Rachel Würstlein et al. · Oncology Research and Treatment · 2001 · 101 citations

Medicine, Oncology, Pharmacotherapy +17

Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study

John M.S. Bartlett, Kenneth J. Bloom, Tammy Piper et al. · Journal of Clinical Oncology · 2012 · 65 citations · Full text

Medicine, Oncology, Breast Oncology +16